These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 16792593)

  • 1. Predicting side-effects in venom immunotherapy by basophil activation?
    Eberlein-König B; Schmidt-Leidescher C; Behrendt H; Ring J
    Allergy; 2006 Jul; 61(7):897. PubMed ID: 16792593
    [No Abstract]   [Full Text] [Related]  

  • 2. High sensitivity of basophils predicts side-effects in venom immunotherapy.
    Kosnik M; Silar M; Bajrovic N; Music E; Korosec P
    Allergy; 2005 Nov; 60(11):1401-6. PubMed ID: 16197472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro basophil activation using CD63 expression in patients with bee and wasp venom allergy.
    Eberlein-König B; Schmidt-Leidescher C; Rakoski J; Behrendt H; Ring J
    J Investig Allergol Clin Immunol; 2006; 16(1):5-10. PubMed ID: 16599242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Basophil activation can predict clinical sensitivity in patients after venom immunotherapy.
    Kucera P; Cvackova M; Hulikova K; Juzova O; Pachl J
    J Investig Allergol Clin Immunol; 2010; 20(2):110-6. PubMed ID: 20461965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hymenoptera-venom-induced upregulation of the basophil activation marker ecto-nucleotide pyrophosphatase/phosphodiesterase 3 in sensitized individuals.
    Platz IJ; Binder M; Marxer A; Lischka G; Valent P; Bühring HJ
    Int Arch Allergy Immunol; 2001 Dec; 126(4):335-42. PubMed ID: 11815741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The basophil activation test in wasp venom allergy: sensitivity, specificity and monitoring specific immunotherapy.
    Erdmann SM; Sachs B; Kwiecien R; Moll-Slodowy S; Sauer I; Merk HF
    Allergy; 2004 Oct; 59(10):1102-9. PubMed ID: 15355470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of basophil activation tests using CD63 or CD203c expression in patients with insect venom allergy.
    Eberlein-König B; Varga R; Mempel M; Darsow U; Behrendt H; Ring J
    Allergy; 2006 Sep; 61(9):1084-5. PubMed ID: 16918511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Monitoring specific immunotherapy using the 3M Diagnostic Systems reagent kits].
    Szymański W; Chyrek-Borowska S
    Pneumonol Alergol Pol; 1991; 59 Suppl 1():23-30. PubMed ID: 1843805
    [No Abstract]   [Full Text] [Related]  

  • 9. [Value of specific IgE and IgG4 measurements in the follow-up of a hymenoptera venom immunotherapy treatment: apropos of 82 cases].
    Sonneville A; Loustanau O; Tahar HA; Menelet I
    Allerg Immunol (Paris); 2000 Jan; 32(1):20-5. PubMed ID: 10723532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hyper-accelerated immunotherapy with Hymenoptera venoms].
    Sabbah A; Bonneau JC; Drouet M; Le Sellin J
    Allerg Immunol (Paris); 1987 Apr; 19(4):156-8, 160, 162-3. PubMed ID: 3453132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Near-fatal anaphylaxis after Hymenoptera venom immunotherapy.
    Wolf BL; Hamilton RG
    J Allergy Clin Immunol; 1998 Sep; 102(3):527-8. PubMed ID: 9768599
    [No Abstract]   [Full Text] [Related]  

  • 12. The local and systemic side-effects of venom and inhaled-allergen subcutaneous immunotherapy.
    Adamic K; Zidarn M; Bajrovic N; Erzen R; Kopac P; Music E
    Wien Klin Wochenschr; 2009; 121(9-10):357-60. PubMed ID: 19562302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Contribution of flow cytometry to allergologic diagnosis].
    Sabbah A; Drouet M; Sainte-Laudry J; Lauret MG; Loiry M
    Allerg Immunol (Paris); 1997 Jan; 29(1):15-21. PubMed ID: 9213415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hymenoptera Anaphylaxis as a Clonal Mast Cell Disorder.
    Bonadonna P; Scaffidi L
    Immunol Allergy Clin North Am; 2018 Aug; 38(3):455-468. PubMed ID: 30007463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hyposensitization to insect venom allergy: small animals--big effect].
    Reiser-Perić P; Schiller S
    Pflege Z; 2002 Jul; 55(7):480-4. PubMed ID: 12192781
    [No Abstract]   [Full Text] [Related]  

  • 16. [Safety of rush immunotherapy with Hymenoptera venom].
    Sánchez-Morillas L; Reaño Martos M; Rodríguez Mosquera M; Iglesias Cadarso A; Domínguez Lázaro AR
    Allergol Immunopathol (Madr); 2005; 33(4):224-7. PubMed ID: 16045862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Individual hymenoptera venom compounds induce upregulation of the basophil activation marker ectonucleotide pyrophosphatase/phosphodiesterase 3 (CD203c) in sensitized patients.
    Binder M; Fierlbeck G; King Ti; Valent P; Bühring HJ
    Int Arch Allergy Immunol; 2002 Oct; 129(2):160-8. PubMed ID: 12403934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ultrarush immunotherapy in patients with Hymenoptera venom allergy.
    Ruëff F; Przybilla B
    J Allergy Clin Immunol; 2001 May; 107(5):928-9. PubMed ID: 11344369
    [No Abstract]   [Full Text] [Related]  

  • 19. The basophil activation test in the diagnosis of allergy: technical issues and critical factors.
    Sturm GJ; Kranzelbinder B; Sturm EM; Heinemann A; Groselj-Strele A; Aberer W
    Allergy; 2009 Sep; 64(9):1319-26. PubMed ID: 19243362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinct Contributory Factors Determine Basophil-Allergen Sensitivity in Grass Pollen Rhinitis and in Anaphylactic Wasp Venom Allergy.
    Korošec P; Šilar M; Kopač P; Eržen R; Zidarn M; Košnik M
    Int Arch Allergy Immunol; 2016; 171(2):89-101. PubMed ID: 27907922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.